DIOSynVax

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

Launch date

Jul 2017

Employees

Company register number 10860446

Cambridge England (HQ)

Date	Investors	Amount	Round
-	University of Bristol Enterprise Fund Parkwalk Advisors	N/A	-
Jan 2017	Cambridge Enterprise University of Cambridge	N/A	Spinout
Apr 2019	Innovate UK	£1.0m	Grant
Jan 2020	N/A	£1.5m	Seed
Aug 2020	Innovate UK	£1.9m	Grant
Mar 2022	Coalition for Epidemic Preparedness	$42.0m	Grant
Total Funding		CAD65.2m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about DIOSynVax